Last reviewed · How we verify
NCT05048290
Communication Skills to Build a Diverse Biomedical Workforce
NA trial testing Communication Skills Training in Behavioral Disorder. Withdrawn.
30 December 2024
Quick facts
| Lead sponsor | M.D. Anderson Cancer Center |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Start date | 19 May 2020 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 December 2024 |
Drugs / interventions tested
- Communication Skills Training
- Communication Skills Training
- Educational Intervention
- Survey Administration
Conditions studied
- Behavioral Disorder — all drugs for Behavioral Disorder →
Sponsor
M.D. Anderson Cancer Center — full company profile →
Who can join
18 and older, any sex, with Behavioral Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial investigates how receiving instruction in communication skills affects short and long-term career outcomes for students, postdoctoral fellows, and future faculty. This may help researchers learn more about the factors that may help or block career goals and career persistence of trainees.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05048290
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Communication Skills Training
Trials testing the same drug.
- NCT05111886 — Effectiveness of an Online Parenting Training · NA · completed
- NCT04660331 — Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study · NA · completed
- NCT03901547 — Emotion Regulation and Burnout Impact on Communication Documentation · NA · withdrawn
- NCT03672942 — Communication Skills vs. Mindfulness for IPV · NA · unknown
- NCT03135782 — Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing R · NA · completed
Other recruiting trials for Behavioral Disorder
Currently open trials in the same condition.
- NCT06852443 — Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT) · NA · recruiting
- NCT04236882 — Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African A · NA · active not recruiting
Other M.D. Anderson Cancer Center trials
Trials by the same sponsor.
- NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
- NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
- NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
- NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
- NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05048290 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05048290.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing